ReviewPeerJ2026
Multi-omics insights into mosquito insecticide resistance for integrated vector management.
Review in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Escalating insecticide resistance in mosquito vectors threatens the durability of vector-borne disease control and increasingly constrains the effectiveness of core interventions. This resistance is a multilayered adaptive phenotype arising from the combined action of target-site substitutions that reduce insecticide sensitivity, transcriptional and enzymatic upregulation of detoxification systems that enhance xenobiotic metabolism, cuticular and behavioral changes that limit exposure and penetration, and transporter-mediated efflux, with additional modulation by microbiota and local environmental conditions that shape phenotypic expression in the field. Current integrated vector management (IVM) strategies aim to mitigate resistance through operationally guided deployment of dual-active-ingredient or synergist-treated nets, indoor residual spraying with rotations or mixtures, integration of larval source management and habitat modification, and incorporation of nonchemical tools such as Wolbachia releases and genetic control, supported by routine resistance surveillance. However, much of the existing evidence remains fragmented, with an overreliance on a narrow set of insecticide classes and a limited number of genetic markers, variable phenotyping and performance metrics across settings, and insufficient prospective linkage between molecular signals and intervention impact under real transmission ecologies. Multi-omics frameworks provide a route to move beyond single-locus screening toward network-level reconstruction of resistance biology, enabling discovery of predictive biomarkers, pathway signatures, and metabolic readouts that can be translated into actionable diagnostics and locally optimized decision rules. Looking forward, omics-enabled precision surveillance integrated with field-deployable assays, standardized benchmarks, and model-informed adaptive management could support closed-loop resistance mitigation in which operational choices are continuously refined to preserve long-term intervention efficacy within IVM programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.